Xenon Pharmaceuticals Inc (XENE)
43.26
+0.06
(+0.14%)
USD |
NASDAQ |
May 07, 13:47
Xenon Pharmaceuticals Cash from Operations (TTM): -145.33M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -145.33M |
September 30, 2023 | -142.59M |
June 30, 2023 | -130.77M |
March 31, 2023 | -114.41M |
December 31, 2022 | -98.43M |
September 30, 2022 | -86.41M |
June 30, 2022 | -71.01M |
March 31, 2022 | -67.22M |
December 31, 2021 | -69.50M |
September 30, 2021 | -61.91M |
June 30, 2021 | -58.05M |
March 31, 2021 | -55.76M |
December 31, 2020 | -48.12M |
September 30, 2020 | -15.22M |
June 30, 2020 | -11.13M |
March 31, 2020 | -9.085M |
December 31, 2019 | -4.714M |
September 30, 2019 | -31.74M |
June 30, 2019 | -38.41M |
Date | Value |
---|---|
March 31, 2019 | -35.20M |
December 31, 2018 | -34.72M |
September 30, 2018 | -34.32M |
June 30, 2018 | -29.22M |
March 31, 2018 | -30.48M |
December 31, 2017 | -28.73M |
September 30, 2017 | -26.56M |
June 30, 2017 | -22.46M |
March 31, 2017 | -21.08M |
December 31, 2016 | -19.57M |
September 30, 2016 | -20.14M |
June 30, 2016 | -20.50M |
March 31, 2016 | -17.50M |
December 31, 2015 | -18.10M |
September 30, 2015 | -15.81M |
June 30, 2015 | -4.638M |
March 31, 2015 | -4.439M |
December 31, 2014 | 0.266M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-145.33M
Minimum
Dec 2023
-4.714M
Maximum
Dec 2019
-66.31M
Average
-61.91M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
Acasti Pharma Inc | -13.57M |
Aurinia Pharmaceuticals Inc | -33.46M |
Edesa Biotech Inc | -6.252M |
Lexaria Bioscience Corp | -5.209M |
ESSA Pharma Inc | -22.19M |